SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-09-026327
Filing Date
2009-04-27
Accepted
2009-04-27 11:56:12
Documents
5
Period of Report
2009-06-09
Effectiveness Date
2009-04-27

Document Format Files

Seq Description Document Type Size
1 DEF 14A a09-10836_1def14a.htm DEF 14A 1029977
2 GRAPHIC g108361bci001.gif GRAPHIC 101780
3 GRAPHIC g108361bci002.gif GRAPHIC 50316
4 GRAPHIC g108361ba03i001.jpg GRAPHIC 4266
5 GRAPHIC g108361ba03i002.jpg GRAPHIC 4267
  Complete submission text file 0001104659-09-026327.txt   1253456
Mailing Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-31812 | Film No.: 09771677
SIC: 2836 Biological Products, (No Diagnostic Substances)